PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
743.76 - 757.57
479.80 - 796.25
8.25M / 11.73M (Avg.)
27.40 | 27.58
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.00%
Negative revenue growth while SNAP stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-9.66%
Negative gross profit growth while SNAP is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-15.10%
Negative EBIT growth while SNAP is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-15.10%
Negative operating income growth while SNAP is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
-26.87%
Negative net income growth while SNAP stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-28.00%
Negative EPS growth while SNAP is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-28.00%
Negative diluted EPS growth while SNAP is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.84%
Share change of 0.84% while SNAP is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.71%
Diluted share change of 0.71% while SNAP is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
7.39%
OCF growth of 7.39% while SNAP is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
12.38%
FCF growth of 12.38% while SNAP is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
322.21%
10Y CAGR of 322.21% while SNAP is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
322.21%
5Y CAGR of 322.21% while SNAP is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
153.95%
3Y CAGR of 153.95% while SNAP is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
329.24%
OCF/share CAGR of 329.24% while SNAP is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
329.24%
OCF/share CAGR of 329.24% while SNAP is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
192.33%
3Y OCF/share CAGR of 192.33% while SNAP is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
90.30%
10Y net income/share CAGR of 90.30% while SNAP is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
90.30%
Net income/share CAGR of 90.30% while SNAP is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
88.29%
3Y net income/share CAGR of 88.29% while SNAP is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
408.11%
Equity/share CAGR of 408.11% while SNAP is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.13%
Firm’s AR is declining while SNAP shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
4.54%
Asset growth of 4.54% while SNAP is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
3.03%
BV/share growth of 3.03% while SNAP is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-20.17%
We’re deleveraging while SNAP stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-4.41%
Our R&D shrinks while SNAP invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-6.29%
We cut SG&A while SNAP invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.